Clinical Trial Update: Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of D-0120 in primary hyperuricemia has completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia

Drugs mentioned

• D-0120

Snippet

Sponsor: InventisBio Co., Ltd | Conditions: Hyperuricemia | Phase 2 | Status: COMPLETED